Actemra subcutaneous injection 162 mg syringe, manufactured by Chugai Pharmaceutical, contains Tocilizumab (genetically recombination). This injectable drug (YJ code: 6399421G1022) is provided as 162mg in 0.9mL per tube and is approved for treating conditions like moderate to severe rheumatoid arthritis and giant cell arteritis.
Actemra subcutaneous injection 162 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →